Search Results - "Pau, Maria Grazia"
-
1
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Published in PloS one (20-02-2018)“…The search for a universal filovirus vaccine that provides protection against multiple filovirus species has been prompted by sporadic but highly lethal…”
Get full text
Journal Article -
2
Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
Published in Journal of Virology (01-05-2011)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
3
Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species
Published in PloS one (06-12-2012)“…Filoviruses cause sporadic but highly lethal outbreaks of hemorrhagic fever in Africa in the human population. Currently, no drug or vaccine is available for…”
Get full text
Journal Article -
4
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Published in PloS one (24-04-2018)“…[This corrects the article DOI: 10.1371/journal.pone.0192312.]…”
Get full text
Journal Article -
5
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults
Published in PloS one (06-07-2015)“…In an observer blind, phase 2 trial, 55 adults were randomized to receive one dose of Ad35.CS.01 vaccine followed by two doses of RTS,S/AS01 (ARR-group) or…”
Get full text
Journal Article -
6
Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans
Published in Frontiers in immunology (01-09-2023)“…In the absence of clinical efficacy data, vaccine protective effect can be extrapolated from animals to humans, using an immunological biomarker in humans that…”
Get full text
Journal Article -
7
Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels
Published in Vaccines (Basel) (01-08-2022)“…The Marburg virus (MARV) and Sudan virus (SUDV) belong to the filovirus family. The sporadic human outbreaks occur mostly in Africa and are characterized by an…”
Get full text
Journal Article -
8
Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates
Published in Journal of Virology (01-10-2010)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
9
A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
Published in PloS one (03-11-2015)“…MVA85A and AERAS-402 are two clinically advanced viral vectored TB vaccine candidates expressing Mycobacterium tuberculosis antigens designed to boost…”
Get full text
Journal Article -
10
Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity
Published in Microbiology spectrum (15-06-2023)“…Vaccine-induced seroreactivity/positivity (VISR/P) poses a significant and common challenge to HIV vaccine implementation, as up to 95% of vaccine recipients…”
Get full text
Journal Article -
11
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age
Published in PloS one (11-11-2013)“…Ad35.CS.01 is a pre-erythrocytic malaria candidate vaccine. It is a codon optimized nucleotide sequence representing the P. falciparum circumsporozoite (CS)…”
Get full text
Journal Article -
12
Genetic immunization in the lung induces potent local and systemic immune responses
Published in Proceedings of the National Academy of Sciences - PNAS (21-12-2010)“…Successful vaccination against respiratory infections requires elicitation of high levels of potent and durable humoral and cellular responses in the lower…”
Get full text
Journal Article -
13
rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector
Published in PloS one (21-11-2008)“…BCG vaccination, combined with adenoviral-delivered boosts, represents a reasonable strategy to augment, broaden and prolong immune protection against…”
Get full text
Journal Article -
14
An alternative to the adenovirus inverted terminal repeat sequence increases the viral genome replication rate and provides a selective advantage in vitro
Published in Journal of general virology (01-07-2014)“…During the development of human adenovirus 35-derived replication-incompetent (rAd35) vaccine vectors for prevention of infectious diseases, we detected…”
Get full text
Journal Article -
15
The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert
Published in Clinical and Vaccine Immunology (01-11-2010)“…ERRATUM ( vol. 18 , p. 353 ) Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg…”
Get full text
Journal Article -
16
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys
Published in Vaccine (19-10-2009)“…Abstract A vaccine that elicits both specific antibodies and IFN-γ-producing T cells is required to protect against pre-erythrocytic malaria. Among the most…”
Get full text
Journal Article -
17
Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults
Published in Human vaccines & immunotherapeutics (01-12-2013)“…Malaria results in over 650 000 deaths each year; thus, there is an urgent need for an effective vaccine. Pre-clinical studies and recently reported human…”
Get full text
Journal Article -
18
A Peptide-Based Plasmodium falciparum Circumsporozoite Assay To Test for Serum Antibody Responses to Pre-Erythrocyte Malaria Vaccines
Published in Clinical and Vaccine Immunology (01-05-2011)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
19
Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized Clinical Trial
Published in JAMA : the journal of the American Medical Association (19-04-2016)“…IMPORTANCE: Developing effective vaccines against Ebola virus is a global priority. OBJECTIVE: To evaluate an adenovirus type 26 vector vaccine encoding Ebola…”
Get full text
Journal Article -
20
HIV Diagnostics and Vaccines: It Takes Two to Tango
Published in The Journal of infectious diseases (14-06-2024)“…Current serologic tests for HIV screening and confirmation of infection present challenges to the adoption of HIV vaccines. The detection of vaccine-induced…”
Get full text
Journal Article